Literature DB >> 16431079

A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse.

Bronwyn A O'Brien1, Xuan Geng, Catherine H Orteu, Yongqian Huang, Mehran Ghoreishi, YiQun Zhang, Jason A Bush, Gang Li, Diane T Finegood, Jan Peter Dutz.   

Abstract

Deficiencies in apoptotic cell clearance have been linked to autoimmunity. Here we examined the time-course of peritoneal macrophage phagocytosis of dying cells following the direct injection of apoptotic thymocytes into the peritoneum of NOD mice and BALB/c controls. Macrophages from NOD mice demonstrated a profound defect in the phagocytosis of apoptotic thymocytes as compared to control macrophages. Nonobese diabetic mice also demonstrated a decrease in the clearance of apoptotic cell loads following an apoptotic stimulus to thymocytes (dexamethasone) when compared to BALB/c or NOR controls. Further, NOD mice demonstrated an increase in apoptotic cell load following an apoptotic stimulus to keratinocytes (ultraviolet light, UVB) when compared to control strains. Animals deficient in macrophage phagocytosis of apoptotic debris often manifest an autoimmune phenotype characterized by the production of antinuclear autoantibodies (ANA). We determined whether increased apoptotic cell loads (through repeated exposure to UVB irradiation) could accelerate such autoimmune phenomena in young NOD mice. Following repeated UVB irradiation, NOD mice, but not BALB/c or NOR controls, developed ANA. We propose that abnormalities in apoptotic cell clearance by macrophages predispose NOD mice to autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16431079     DOI: 10.1016/j.jaut.2005.11.006

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  45 in total

Review 1.  Innate and adaptive immune response to apoptotic cells.

Authors:  Yufeng Peng; David A Martin; Justin Kenkel; Kang Zhang; Carol Anne Ogden; Keith B Elkon
Journal:  J Autoimmun       Date:  2007-09-20       Impact factor: 7.094

Review 2.  Nucleic acids in circulation: are they harmful to the host?

Authors:  Indraneel Mittra; Naveen Kumar Nair; Pradyumna Kumar Mishra
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

Review 3.  Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes.

Authors:  F Susan Wong; Li Wen
Journal:  Rev Diabet Stud       Date:  2012-12-28

4.  Ageing is associated with diminished apoptotic cell clearance in vivo.

Authors:  T Aprahamian; Y Takemura; D Goukassian; K Walsh
Journal:  Clin Exp Immunol       Date:  2008-04-16       Impact factor: 4.330

5.  Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity.

Authors:  Magloire Pandoua Nekoua; Antoine Bertin; Famara Sane; Enagnon Kazali Alidjinou; Delphine Lobert; Jacques Trauet; Christine Hober; Ilka Engelmann; Kabirou Moutairou; Akadiri Yessoufou; Didier Hober
Journal:  Cell Mol Life Sci       Date:  2019-06-06       Impact factor: 9.261

6.  Initiating type I diabetes: new suspects in the lineup.

Authors:  Rémi J Creusot
Journal:  Nat Med       Date:  2013-01       Impact factor: 53.440

7.  Desiccating environmental stress exacerbates autoimmune lacrimal keratoconjunctivitis in non-obese diabetic mice.

Authors:  Kyung-Chul Yoon; Cintia S De Paiva; Hong Qi; Zhuo Chen; William J Farley; De-Quan Li; Michael E Stern; Stephen C Pflugfelder
Journal:  J Autoimmun       Date:  2007-11-07       Impact factor: 7.094

8.  Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes.

Authors:  Julien Diana; Yannick Simoni; Laetitia Furio; Lucie Beaudoin; Birgitta Agerberth; Franck Barrat; Agnès Lehuen
Journal:  Nat Med       Date:  2012-12-16       Impact factor: 53.440

9.  Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells.

Authors:  Thomas Enzler; Silke Gillessen; Michael Dougan; James P Allison; Donna Neuberg; Darryl A Oble; Martin Mihm; Glenn Dranoff
Journal:  Blood       Date:  2007-05-04       Impact factor: 22.113

Review 10.  Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases.

Authors:  Matthew Spite; Joan Clària; Charles N Serhan
Journal:  Cell Metab       Date:  2013-11-14       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.